<?xml version="1.0" encoding="UTF-8"?>
<ref id="B51">
 <label>51.</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Parra</surname>
    <given-names>GI</given-names>
   </name>
   <name>
    <surname>Bok</surname>
    <given-names>K</given-names>
   </name>
   <name>
    <surname>Taylor</surname>
    <given-names>R</given-names>
   </name>
   <name>
    <surname>Haynes</surname>
    <given-names>JR</given-names>
   </name>
   <name>
    <surname>Sosnovtsev</surname>
    <given-names>SV</given-names>
   </name>
   <name>
    <surname>Richardson</surname>
    <given-names>C</given-names>
   </name>
   <etal/>
  </person-group>. 
  <article-title>Immunogenicity and specificity of norovirus consensus GII.4 virus-like particles in monovalent and bivalent vaccine formulations</article-title>. 
  <source>Vaccine.</source> (
  <year>2012</year>) 
  <volume>30</volume>:
  <fpage>3580</fpage>â€“
  <lpage>6</lpage>. 
  <pub-id pub-id-type="doi">10.1016/j.vaccine.2012.03.050</pub-id>
  <?supplied-pmid 22469864?>
  <pub-id pub-id-type="pmid">22469864</pub-id>
 </mixed-citation>
</ref>
